ArticleWorld journal of surgical oncology2024
Efficacy and safety of neoadjuvant S-1-based chemoradiotherapy in resectable and borderline-resectable pancreatic cancer: a long-term follow-up study.
Gaku Shimane et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.